Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Times Interest Earned (2016 - 2026)

Collegium Pharmaceutical has reported Times Interest Earned over the past 9 years, most recently at $3.15 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 87.2% year-over-year to $3.15; the TTM value through Dec 2025 reached $2.18, down 4.98%, while the annual FY2025 figure was $2.18, 4.98% down from the prior year.
  • Times Interest Earned for Q4 2025 was $3.15 at Collegium Pharmaceutical, up from $2.85 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $3.7 in Q1 2021 and troughed at -$7.17 in Q4 2021.
  • A 5-year average of $1.46 and a median of $1.8 in 2024 define the central range for Times Interest Earned.
  • Biggest five-year swings in Times Interest Earned: tumbled 470.08% in 2021 and later soared 459.91% in 2023.
  • Year by year, Times Interest Earned stood at -$7.17 in 2021, then soared by 107.97% to $0.57 in 2022, then soared by 459.91% to $3.2 in 2023, then tumbled by 47.42% to $1.68 in 2024, then surged by 87.2% to $3.15 in 2025.
  • Business Quant data shows Times Interest Earned for COLL at $3.15 in Q4 2025, $2.85 in Q3 2025, and $1.72 in Q2 2025.